A lack of supersensitivity to opioid receptor agonists following chronic spinal opioid receptor antagonist administration in the rat.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  General Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0306-3623(94)00154-FPMID 7713356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat.

  1993cited by this paper
• delta-Opioid receptor subtypes and cross-talk with mu-receptors.

  1993cited by this paper
• δ-opioid receptor subtypes and cross-talk with μ-receptors

  1993cited by this paper
• Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.

  1993cited by this paper
• Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).

  1992cited by this paper
• Interaction of opioid peptides and other drugs with multiple delta ncx binding sites in rat brain: further evidence for heterogeneity.

  1992cited by this paper
• Interaction of opioid peptides and other drugs with multiple δncx binding sites in rat brain: Further evidence for heterogeneity

  1992cited by this paper
• Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.

  1992cited by this paper
• Response of intractable pain to continuous intrathecal morphine: a retrospective study

  1992cited by this paper
• Species differences in mu- and delta-opioid receptors.

  1991cited by this paper
• Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.

  1991cited by this paper
• Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats.

  1991cited by this paper
• Species differences in μ- and δ-opioid receptors

  1991cited by this paper
• Inability of an opioid antagonist lacking negative intrinsic activity to induce opioid receptor up‐regulation in vivo

  1991cited by this paper
• Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.

  1990cited by this paper
• Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.

  1990cited by this paper
• δ‐Opioid receptor binding sites in rodent spinal cord

  1990cited by this paper
• Chronic opioid antagonist treatment increases μ and δ receptor mediated spinal cord opioid analgesia

  1989cited by this paper
• Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia.

  1989cited by this paper
• Chronic opioid antagonist treatment: assessment of receptor upregulation.

  1989cited by this paper
• Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.

  1989cited by this paper
• Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.

  1988cited by this paper
• beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.

  1988cited by this paper
• Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.

  1988cited by this paper
• Morphine-induced downregulation of mu-opioid receptors in neonatal rat brain.

  1988cited by this paper
• Simultaneous modulation of TRH and opioid receptor binding in rat spinal cord after chronic naloxone administration.

  1988cited by this paper
• Litchfield and Wilcoxon I: Confidence Limits of ED50

  1987cited by this paper
• Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.

  1987cited by this paper
• Chronic antagonist infusion does not increase morphine antinociception in rat spinal cord.

  1987cited by this paper
• Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.

  1986cited by this paper
• Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.

  1985cited by this paper
• The physiology and pharmacology of spinal opiates.

  1985cited by this paper
• Analgesics : neurochemical, behavioral, and clinical perspectives

  1984cited by this paper
• Differential association of spinal mu, delta and kappa opioid receptors with cutaneous thermal and visceral chemical nociceptive stimuli in the rat.

  1983cited by this paper
• Autoradiography of [3H]beta-endorphin binding in brain.

  1983cited by this paper
• Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat.

  1983cited by this paper
• Autoradiography of [3H]β-endorphin binding in brain

  1983cited by this paper
• Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system.

  1983cited by this paper
• Differential association of spinal μ, δ and κ opioid receptors with cutaneous thermal and visceral chemical nociceptive stimuli in the rat

  1983cited by this paper
• In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord.

  1982cited by this paper
• Pharmacological characterization of the epsilon-opiate receptor.

  1981cited by this paper
• An improved method for chronic catheterization of the rat spinal subarachnoid space.

  1981cited by this paper
• Enhanced analgesic effects of morphine after chronic administration of naloxone in the rat.

  1978cited by this paper
• Chronic naloxone results in prolonged increases in opiate binding sites in brain.

  1978cited by this paper
• Endogenous opioid peptides: multiple agonists and receptors

  1977cited by this paper
• Opiate receptor binding--enhancement by opiate administration in vivo.

  1976cited by this paper
• The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

  1976cited by this paper
• Binding of 3H-naloxone in the mouse brain: effect of ions and tolerance development.

  1974cited by this paper
• The effect of N-allylnormorphine upon the development of tolerance to morphine in the albino rat.

  1953cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper
• A METHOD FOR DETERMINING LOSS OF PAIN SENSATION

  1941cited by this paper

• Acute antinociceptive effect of fish oil or its major compounds, eicosapentaenoic and docosahexaenoic acids on diabetic neuropathic pain depends on opioid system activation.

  2019cites this paper
• Depression of C fibre-evoked spinal field potentials by the spinal delta opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: involvement of the mu-subtype.

  2008cites this paper
• Effect of centrally administered opioid receptor agonists on CSF and plasma oxytocin concentrations in dogs.

  2001cites this paper
• Evidence that spinal endogenous opioidergic systems control the expression of chronic pain-related behaviors in spinally injured rats

  1998cites this paper